Dr. David Gerber, MD
Claim this profileUT Southwestern/Simmons Cancer Center-Dallas
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
9 reported clinical trials
16 drugs studied
Area of expertise
1Lung Cancer
Stage III
Stage II
Stage I
2Non-Small Cell Lung Cancer
Stage III
Stage II
Stage I
Affiliated Hospitals
Clinical Trials David Gerber, MD is currently running
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
More about David Gerber, MD
Clinical Trial Related9 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments David Gerber, MD has experience with
- TVB-2640
- Durvalumab
- Thoracic RT
- Selinexor
- Docetaxel
- Brigatinib
Breakdown of trials David Gerber, MD has run
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
KRAS Mutation
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David Gerber, MD specialize in?
David Gerber, MD focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage III patients, or patients who are Stage II.
Is David Gerber, MD currently recruiting for clinical trials?
Yes, David Gerber, MD is currently recruiting for 4 clinical trials in Dallas Texas. If you're interested in participating, you should apply.
Are there any treatments that David Gerber, MD has studied deeply?
Yes, David Gerber, MD has studied treatments such as TVB-2640, Durvalumab, Thoracic RT.
What is the best way to schedule an appointment with David Gerber, MD?
Apply for one of the trials that David Gerber, MD is conducting.
What is the office address of David Gerber, MD?
The office of David Gerber, MD is located at: UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas 75390 United States. This is the address for their practice at the UT Southwestern/Simmons Cancer Center-Dallas.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.